Showing results (21-30 of 146) with videos related to

Sort By:
Pageof 15
Frontiers in Oncology|March 6, 2020
Insights Into Genetic Landscape of Large Granular Lymphocyte LeukemiaAntonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.
Blood Cancer Journal|January 18, 2024
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disordersGianpietro Semenzato, Giulia Calabretto, Antonella Teramo, et al.
Best Practice & Research. Clinical Haematology|October 6, 2019
T cell large granular lymphocyte leukemia and chronic NK lymphocytosisGregorio Barilà, Giulia Calabretto, Antonella Teramo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2012
The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignanciesAmbrogio Fassina, Filippo Marino, Maayan Siri, et al.
Leukemia Research|September 20, 2006
T-cell type lymphoproliferative disease of granular lymphocytes (LDGL) is equipped with a phenotypic pattern typical of effector cytotoxic cellsIlenia Baesso, Laura Pavan, Elisa Boscaro, et al.
Dentistry Journal|January 27, 2021
The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma PatientsChristian Bacci, Alessia Cerrato, Virginia Dotto, et al.
American Journal of Hematology|September 13, 2025
Independent Origin of Hairy Cell Leukemia (HCL) From Co-Occurring Clonal Hematopoiesis (CH)Alessandra Venanzi, Alessia Santi, Renato Zambello, et al.
British Journal of Haematology|March 5, 2003
Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytesRenato Zambello, Livio Trentin, Monica Facco, et al.
Cancers|November 11, 2022
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in EuropeEvangelos Terpos, Renato Zambello, Xavier Leleu, et al.
Ejhaem|February 23, 2023
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and IsraelXavier Leleu, Eirini Katodritou, Thomas Kuehr, et al.
Pageof 15